pport of this promising Young Investigator Award and of the goal of the MRA to foster the next generation of melanoma research leaders. Sincerely, Michael Kaplan President and Chief Executive Officer The Melanoma Research Alliance Foundation is a 501(c)3 nonprofit organization. 1101 New York Avenue, NW, Sui

f the outstanding research procured through our global peer review grant process, providing unique access to leading scientists in the field," says Michael Kaplan, CEO and president of MRA. "These awards not only will lead to the advancement of research for improved treatments and leveraging of additional fun